Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. (Q53192091)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 March 2016

Language	Label	Description	Also known as
English	Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia.	scientific article published on 3 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

0 references

intrauterine growth restriction

1 reference

based on heuristic

inferred from title

author name string

Ertac Gumus

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Mehmet Aral Atalay

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Bilge Cetinkaya Demir

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Esra Sahin Gunes

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

publication date

3 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Journal of Maternal-Fetal and Neonatal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

29

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

23

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

3806-3811

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Serum iron and copper status and oxidative stress in severe and mild preeclampsia.

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Could antioxidant supplementation prevent pre-eclampsia?

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries.

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Early detection of preeclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

The DDAH/ADMA/NOS pathway

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2016.1147551

21 January 2018

Identifiers

10.3109/14767058.2016.1147551

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26821682

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53192091&oldid=1630671560"